Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRS3 | P32247 | 1/20 | 0.46 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.45 |
| ▸ | AGTR2 | P50052 | 2/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9534250 | 0.91 | BRS3 (0.49) | BRS3AGTR1AGTR2PPARG | |
| SCHEMBL9531747 | 0.90 | BRS3 (0.46) | BRS3AGTR1AGTR2PPARG | |
| SCHEMBL9530900 | 0.90 | PPARG (0.52) | AGTR1AGTR2PPARG | |
| SCHEMBL9531621 | 0.89 | BRS3 (0.47) | BRS3AGTR1AGTR2 | |
| SCHEMBL9555096 | 0.89 | BRS3 (0.47) | BRS3AGTR1AGTR2 | |
| SCHEMBL9554043 | 0.89 | BRS3 (0.47) | BRS3AGTR1AGTR2PPARG | |
| SCHEMBL9531420 | 0.89 | AGTR1 (0.48) | BRS3AGTR1AGTR2PPARG | |
| SCHEMBL9536641 | 0.89 | BRS3 (0.47) | BRS3AGTR1AGTR2PPARG | |
| SCHEMBL9533625 | 0.89 | AGTR1 (0.48) | BRS3AGTR1AGTR2PPARG | |
| SCHEMBL9533675 | 0.88 | PPARG (0.46) | BRS3AGTR1AGTR2PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5238952-A | Treating glaucoma disorders | G. D. SEARLE & CO. (US) | 1993-08-24 | — | — | US | disclosed |
| EP-0555331-A1 | N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. | SEARLE & CO (US) | 1993-08-18 | — | — | EP | disclosed |
| WO-1992007834-A1 | N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1992-05-14 | — | — | WO | disclosed |
| US-5087634-A | N-substituted imidazol-2-one compounds for treatment of circulatory disorders | G. D. SEARLE & CO. (US) | 1992-02-11 | — | — | US | disclosed |